Roles of Cell Division and Gene Transcription in the Methylation of CpG Islands

ABSTRACT De novo methylation of CpG islands within the promoters of eukaryotic genes is often associated with their transcriptional repression, yet the methylation of CpG islands located downstream of promoters does not block transcription. We investigated the kinetics of mRNA induction, demethylation, and remethylation of the p16promoter and second-exon CpG islands in T24 cells after 5-aza-2′-deoxycytidine (5-Aza-CdR) treatment to explore the relationship between CpG island methylation and gene transcription. The rates of remethylation of both CpG islands were associated with time but not with the rate of cell division, and remethylation of thep16 exon 2 CpG island occurred at a higher rate than that of the p16 promoter. We also examined the relationship between the remethylation of coding sequence CpG islands and gene transcription. The kinetics of remethylation of the p16exon 2, PAX-6 exon 5, c-ABL exon 11, andMYF-3 exon 3 loci were examined following 5-Aza-CdR treatment because these genes contain exonic CpG islands which are hypermethylated in T24 cells. Remethylation occurred most rapidly in the p16, PAX-6, and c-ABL genes, shown to be transcribed prior to drug treatment. These regions also exhibited higher levels of remethylation in single-cell clones and subclones derived from 5-Aza-CdR-treated T24 cells. Our data suggest that de novo methylation is not restricted to the S phase of the cell cycle and that transcription through CpG islands does not inhibit their remethylation.

[1]  G. Liang,et al.  PAX6 methylation and ectopic expression in human tumor cells , 2000, International journal of cancer.

[2]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[3]  Hung D. Nguyen,et al.  DNA methylation differences associated with tumor tissues identified by genome scanning analysis. , 1998, Genomics.

[4]  A. Bird,et al.  An Alternative Promoter in the Mouse Major Histocompatibility Complex Class II I-Aβ Gene: Implications for the Origin of CpG Islands , 1998, Molecular and Cellular Biology.

[5]  E. Li,et al.  Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases , 1998, Nature Genetics.

[6]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[7]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[8]  P. Jones,et al.  The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. , 1998, Cancer research.

[9]  E. Wagner,et al.  Imprinted expression of the Igf2r gene depends on an intronic CpG island , 1997, Nature.

[10]  C. Hsieh.  Stability of patch methylation and its impact in regions of transcriptional initiation and elongation , 1997, Molecular and cellular biology.

[11]  Stephen B. Baylin,et al.  Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions inde Novo Methylation* , 1997, The Journal of Biological Chemistry.

[12]  P. Jones,et al.  Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). , 1997, Nucleic acids research.

[13]  S. Baylin,et al.  Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Jones,et al.  DNA methylation errors and cancer. , 1996, Cancer research.

[15]  J. Herman,et al.  Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. , 1996, Cancer research.

[16]  R. Beart,et al.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.

[17]  J. Herman,et al.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.

[18]  C. D. Edwards,et al.  A novel p16INK4A transcript. , 1995, Cancer research.

[19]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[20]  Y. Ben-Neriah,et al.  Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Herman,et al.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Bird,et al.  Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. , 1994, Genes & development.

[23]  Z. Siegfried,et al.  Spl elements protect a CpG island from de novo methylation , 1994, Nature.

[24]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[25]  C. Hsieh,et al.  Dependence of transcriptional repression on CpG methylation density , 1994, Molecular and cellular biology.

[26]  P. Jones,et al.  Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer , 1994, Molecular and cellular biology.

[27]  S. Baylin,et al.  Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. , 1994, Cancer research.

[28]  S. Kass,et al.  Inactive chromatin spreads from a focus of methylation , 1993, Molecular and cellular biology.

[29]  Rudolf Jaenisch,et al.  Role for DNA methylation in genomic imprinting , 1993, Nature.

[30]  B. Tycko,et al.  Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. , 1993, American journal of human genetics.

[31]  M. Azim Surani,et al.  Parental-origin-specific epigenetic modification of the mouse H19 gene , 1993, Nature.

[32]  H. Prydz,et al.  CpG islands as gene markers in the human genome. , 1992, Genomics.

[33]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[34]  A. Riggs,et al.  X-chromosome inactivation and cell memory. , 1992, Trends in genetics : TIG.

[35]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Szyf,et al.  Growth regulation of mouse DNA methyltransferase gene expression. , 1991, The Journal of biological chemistry.

[37]  T. Dryja,et al.  Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. , 1991, American journal of human genetics.

[38]  A. Bird,et al.  High levels of De Novo methylation and altered chromatin structure at CpG islands in cell lines , 1990, Cell.

[39]  P. Jones,et al.  Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance , 1987, Molecular and cellular biology.

[40]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[41]  C. Caskey,et al.  Methylation of the mouse hprt gene differs on the active and inactive X chromosomes , 1986, Molecular and cellular biology.

[42]  P. Jones,et al.  Mechanism of action of eukaryotic DNA methyltransferase. Use of 5-azacytosine-containing DNA. , 1982, Journal of molecular biology.

[43]  P. Jones,et al.  Hemimethylated duplex DNAs prepared from 5-azacytidine-treated cells. , 1981, Nucleic acids research.

[44]  T. Mohandas,et al.  Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. , 1981, Science.

[45]  Peter A. Jones,et al.  Cellular differentiation, cytidine analogs and DNA methylation , 1980, Cell.

[46]  P. Jones,et al.  Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment , 1977, Nature.

[47]  P. Jones,et al.  The DNA methylation paradox. , 1999, Trends in genetics : TIG.

[48]  P. Jones,et al.  Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. , 1998, Cancer research.

[49]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[50]  M. Zion.  DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia , 1994 .

[51]  A. Bird,et al.  Effects of DNA methylation on DNA-binding proteins and gene expression. , 1993, Current opinion in genetics & development.

[52]  A. Bird.  CpG islands as gene markers in the vertebrate nucleus , 1987 .

[53]  A. Riggs,et al.  DNA methylation, biochemistry, and biological significance , 1984 .

[54]  A. Razin.  DNA Methylation Patterns: Formation and Biological Functions , 1984 .

[55]  A. Razin,et al.  Effect of DNA methylation on gene expression. , 1983, Cold Spring Harbor symposia on quantitative biology.